Apollo’s John Zito questions private equity’s software valuations: ‘All the marks are wrong’

Apollo’s John Zito questions private equity’s software valuations: ‘All the marks are wrong’


Key Points
  • Apollo executive John Zito said private equity firms are broadly misstating the value of their software holdings, telling UBS clients last month that “all the marks are wrong.”
  • Zito warned that lenders to smaller software companies could recover as little as 20 to 40 cents on the dollar, implying deep losses.
  • Apollo sought to distance itself from the damage, telling analysts that software companies represent less than 2% of the firm’s assets under management and that it has zero exposure to private equity stakes in software firms.



Source

Stocks making the biggest moves premarket: Netflix, Soleno Therapeutics, Strategy & more
Finance

Stocks making the biggest moves premarket: Netflix, Soleno Therapeutics, Strategy & more

Check out the companies making the biggest moves premarket: Netflix — The streaming platform climbed 1.5% after a Goldman Sachs upgrade to buy from neutral. The bank said it sees Netflix as continuing to be the leader in content acquisition and development, and a high chance for multiyear capital return back to shareholders. Soleno Therapeutics […]

Read More
Stocks making the biggest moves premarket: Exxon Mobil, Carnival, Delta, General Motors and more
Finance

Stocks making the biggest moves premarket: Exxon Mobil, Carnival, Delta, General Motors and more

Check out the companies making the biggest moves in premarket trading: Oil stocks — Shares of energy companies jumped alongside the move higher in oil prices , which surged more than 7% after President Donald Trump’s speech Wednesday night indicated the war in Iran would continue. APA gained 4.3%, while Diamondback Energy , ConocoPhillips , […]

Read More
Stocks making the biggest moves midday: Eli Lilly, Hasbro, Philip Morris, Intel, Micron & more
Finance

Stocks making the biggest moves midday: Eli Lilly, Hasbro, Philip Morris, Intel, Micron & more

Check out the companies making the biggest moves in midday trading: Eli Lilly — The Food and Drug Administration approved Foundayo , the company’s once-a-day GLP-1 pill to treat obesity. Shares rose about 4% on the news. Hasbro — The toymaker fell more than 4% after it disclosed a cybersecurity incident where there was unauthorized […]

Read More